| Financier | Commitments |
|---|---|
| International Bank for Reconstruction and Development | 100.00 |
Turkey Emergency COVID-19 Health Project
Abstract*
The Project consists of two components to support the government to curb the spread of COVID-19 pandemic and strengthen health system to detect and treat cases. Components will include: (i) Emergency COVID-19 Response (indicatively, US$98M) and (ii) Project Management, Monitoring and Evaluation (indicatively, US$2M).
The project has been designed based on a theory of change that links access to essential services and information to clinical and behavioral... Show More
Development Objective
The Project development objective is to prevent, detect, and respond to the threat posed by COVID-19 in Turkey.
Key Details
Project Details
P173988
Closed
Nadwa Rafeh
Ministry of Treasury and Finance
April 15, 2020
(as of board presentation)
April 24, 2020
May 27, 2020
US$ 100.00 million
Ministry of Health
2020
US$ 100.00 million
N/A
Substantial
March 29, 2024
Yes
BANK APPROVED
June 23, 2024
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | 100.00 |
| IDA Commitment | N/A |
| IBRD + IDA Commitment | 100.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 100.00 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Dec 9, 2022 | IBRD-93930 | Loan Disb | 428,101,888.00 |
| Dec 16, 2022 | IBRD-93930 | Loan Disb | 47,402,424.00 |
| Jul 15, 2024 | IBRD-91030 | Int Charges | 43,581.51 |
| Jul 15, 2024 | IBRD-91030 | Int Charges | 2,553.73 |
| Apr 24, 2020 | IBRD-91030 | Loan Commitment | 100,000,000.00 |
| May 26, 2022 | IBRD-93930 | Loan Commitment | 500,000,000.00 |
| Jul 15, 2024 | IBRD-91030 | Int Charges | 2,221,502.00 |
| Jan 15, 2024 | IBRD-91030 | Int Charges | 10,143.70 |
| Jan 15, 2024 | IBRD-91030 | Int Charges | 2,046,045.80 |
| Apr 15, 2024 | IBRD-93930 | Int Charges | 11,106,206.00 |
| Apr 15, 2024 | IBRD-93930 | Int Charges | 8.57 |
| May 16, 2024 | IBRD-93930 | Loan Disb | -109,420.14 |
| May 16, 2024 | IBRD-91030 | Loan Disb | -911,566.60 |
| Jul 29, 2024 | IBRD-91030 | Loan Cancel | 908,548.20 |
| Dec 15, 2020 | IBRD-91030 | Loan Disb | 10,429,823.00 |
| Aug 4, 2020 | IBRD-91030 | Loan Disb | 3,531,000.00 |
| May 16, 2024 | IBRD-93930 | Loan Cancel | 109,420.14 |
| Jul 15, 2022 | IBRD-91030 | Int Charges | 12,406.66 |
| Aug 9, 2022 | IBRD-93930 | Fee Charges | 1,152,214.50 |
| Jan 15, 2022 | IBRD-91030 | Int Charges | 27,537.62 |
| Sep 14, 2021 | IBRD-91030 | Loan Disb | 32,507,694.00 |
| Jul 15, 2021 | IBRD-91030 | Int Charges | 3,641.52 |
| Dec 11, 2020 | IBRD-91030 | Loan Disb | 18,183,750.00 |
| Jul 15, 2021 | IBRD-91030 | Int Charges | 8,915.52 |
| Jan 15, 2021 | IBRD-91030 | Int Charges | 2,816.82 |
| Dec 3, 2020 | IBRD-91030 | Loan Disb | 10,916,100.00 |
| Dec 8, 2020 | IBRD-91030 | Loan Disb | 3,874,080.00 |
| Dec 23, 2020 | IBRD-91030 | Loan Disb | 6,257,998.50 |
| Dec 28, 2020 | IBRD-91030 | Loan Disb | 12,194,500.00 |
| Jun 3, 2020 | IBRD-91030 | Fee Charges | 255,920.00 |
| Nov 27, 2023 | IBRD-93930 | Loan Disb | 465,545.00 |
| Oct 15, 2023 | IBRD-93930 | Int Charges | 9,459,753.00 |
| Dec 6, 2023 | IBRD-93930 | Loan Disb | 80,850.00 |
| Dec 8, 2023 | IBRD-91030 | Loan Disb | 8,211,661.50 |
| Dec 13, 2023 | IBRD-91030 | Loan Disb | 1,722,615.20 |
| Jul 15, 2023 | IBRD-91030 | Int Charges | 12,922.19 |
| Jul 15, 2023 | IBRD-91030 | Int Charges | 1,537,810.80 |
| Jan 15, 2023 | IBRD-91030 | Int Charges | 13,556.44 |
| Jan 15, 2023 | IBRD-91030 | Int Charges | 387,094.30 |
| Feb 3, 2023 | IBRD-91030 | Loan Disb | 804,559.20 |
| Apr 15, 2023 | IBRD-93930 | Int Charges | 4,349,366.00 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Overall Implementation Progress (IP) | Satisfactory | 2024-12-13 |
| Progress towards achievement of PDO | Highly Satisfactory | 2024-12-13 |
| Procurement | Satisfactory | 2024-12-13 |
| Project Management | Satisfactory | 2024-12-13 |
| Financial Management | Satisfactory | 2024-12-13 |
| Monitoring and Evaluation | Highly Satisfactory | 2024-12-13 |
| Progress towards achievement of PDO | Satisfactory | 2024-12-13 |
| Financial Management | Satisfactory | 2024-12-13 |
| Overall Implementation Progress (IP) | Satisfactory | 2024-12-13 |
| Counterpart Funding | Satisfactory | 2024-12-13 |
| Procurement | Satisfactory | 2024-12-13 |
| Project Management | Satisfactory | 2024-12-13 |
| Monitoring and Evaluation | Moderately Satisfactory | 2024-12-13 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Number of people tested for COVID-19 identification per approved protocol under the Project (cumulative) Value 0.00 9357600.00 300000.00 Date April 2, 2020 March 29, 2024 March 29, 2024 Comment Diagnosed cases treated per approved protocol under the Project (cumulative) Value 0.00 65.74 25.00 Date April 2, 2020 March 29, 2024 March 29, 2024 Comment Percentage of population vaccinated, which is included in the priority population targets defined in national plan (by gender) Value 62.90 69.00 66.00 Date March 14, 2022 March 29, 2024 March 29, 2024 Comment Percentage of population vaccinated, which is included in the priority population targets defined in national plan (males) Value 61.30 67.60 65.30 Date March 14, 2022 March 29, 2024 March 29, 2024 Comment Percentage of population vaccinated, which is included in the priority population targets defined in national plan (females) Value 62.70 68.40 66.70 Date March 14, 2022 March 29, 2024 March 29, 2024 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Number of laboratories with COVID-19 diagnostic equipment, test kits, and reagents under the Project Value 0.00 300.00 35.00 Date April 2, 2020 March 29, 2024 March 29, 2024 Comment Number of ICU beds equipped with mechanical ventilators procured under the Project (cumulative) Value 0.00 4000.00 3500.00 Date April 2, 2020 March 29, 2024 March 29, 2024 Comment Number of health staff equipped with Personal Protective Equipment (PPEs) procured under the Project Value 0.00 831215.00 90000.00 Date April 2, 2020 March 29, 2024 March 29, 2024 Comment Country has reported to have contextualized their risk communication and community engagement strategies Value No Yes Yes Date April 2, 2020 March 29, 2024 March 29, 2024 Comment Established and functioning M&E system supporting epidemic preparedness and response Value Yes Yes Yes Date December 15, 2022 March 29, 2024 March 29, 2024 Comment Vaccine stock management tools and operating procedures updated to reflect the characteristics of COVID-19 vaccines. Value No Yes Yes Date February 1, 2022 March 29, 2024 March 29, 2024 Comment Standard operating procedures (SOPs) or guidelines established for collection and disposal of medical waste to the relevant stakeholders Value No Yes Yes Date February 1, 2022 March 29, 2024 March 29, 2024 Comment